Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 247

1.

Adenosine and verapamil for no-reflow during primary percutaneous coronary intervention in people with acute myocardial infarction.

Aung Naing K, Li L, Su Q, Wu T.

Cochrane Database Syst Rev. 2013 Jun 4;(6):CD009503. doi: 10.1002/14651858.CD009503.pub2. Review. Update in: Cochrane Database Syst Rev. 2015;(5):CD009503.

PMID:
23736949
2.

Adenosine and verapamil for no-reflow during primary percutaneous coronary intervention in people with acute myocardial infarction.

Su Q, Nyi TS, Li L.

Cochrane Database Syst Rev. 2015 May 18;(5):CD009503. doi: 10.1002/14651858.CD009503.pub3. Review.

PMID:
25985145
3.
4.

Effect of intracoronary nitroprusside in preventing no reflow phenomenon during primary percutaneous coronary intervention: a meta-analysis.

Zhao S, Qi G, Tian W, Chen L, Sun Y.

J Interv Cardiol. 2014 Aug;27(4):356-64. doi: 10.1111/joic.12133. Review.

PMID:
25041036
5.

Effects of verapamil and adenosine in an adjunct to tirofiban on resolution and prognosis of noreflow phenomenon in patients with acute myocardial infarction.

Faruk Akturk I, Arif Yalcin A, Biyik I, Sarikamis C, Turhan Caglar N, Erturk M, Celik O, Uzun F, Murat Caglar I, Oner E.

Minerva Cardioangiol. 2014 Oct;62(5):389-97.

PMID:
24699550
6.

Safety and efficacy of intracoronary adenosine administration in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: a meta-analysis of randomized controlled trials.

Singh M, Shah T, Khosla K, Singh P, Molnar J, Khosla S, Arora R.

Ther Adv Cardiovasc Dis. 2012 Jun;6(3):101-14. doi: 10.1177/1753944712446670. Review.

PMID:
22562999
7.

Prophylactic lidocaine for myocardial infarction.

Martí-Carvajal AJ, Simancas-Racines D, Anand V, Bangdiwala S.

Cochrane Database Syst Rev. 2015 Aug 21;(8):CD008553. doi: 10.1002/14651858.CD008553.pub2. Review.

PMID:
26295202
8.

Routine invasive strategies versus selective invasive strategies for unstable angina and non-ST elevation myocardial infarction in the stent era.

Fanning JP, Nyong J, Scott IA, Aroney CN, Walters DL.

Cochrane Database Syst Rev. 2016 May 26;(5):CD004815. doi: 10.1002/14651858.CD004815.pub4. Review.

PMID:
27226069
10.

Perioperative beta-blockers for preventing surgery-related mortality and morbidity.

Blessberger H, Kammler J, Domanovits H, Schlager O, Wildner B, Azar D, Schillinger M, Wiesbauer F, Steinwender C.

Cochrane Database Syst Rev. 2014 Sep 18;(9):CD004476. doi: 10.1002/14651858.CD004476.pub2. Review.

PMID:
25233038
11.

Verapamil reverses myocardial no-reflow after primary percutaneous coronary intervention in patients with acute myocardial infarction.

Fu Q, Lu W, Huang YJ, Wu Q, Wang LG, Wang HB, Jiang SZ, Wang YJ.

Cell Biochem Biophys. 2013;67(3):911-4. doi: 10.1007/s12013-013-9581-0.

PMID:
23559273
12.

Tong-xin-luo capsule for patients with coronary heart disease after percutaneous coronary intervention.

Mao C, Fu XH, Yuan JQ, Yang ZY, Chung VC, Qin Y, Huang Y, Tam WW, Kwong JS, Xie W, Tang JL.

Cochrane Database Syst Rev. 2015 May 21;(5):CD010237. doi: 10.1002/14651858.CD010237.pub2. Review.

PMID:
25994229
13.

Usefulness of monocyte chemoattractant protein-1 to predict no-reflow and three-year mortality in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.

Buyukkaya E, Poyraz F, Karakas MF, Kurt M, Akcay AB, Akpinar I, Motor S, Turak O, Ozturk OH, Sen N, Akpek M, Kaya MG, Gibson CM.

Am J Cardiol. 2013 Jul 15;112(2):187-93. doi: 10.1016/j.amjcard.2013.03.011.

PMID:
23601576
14.

Dipyridamole versus verapamil for treatment of no-reflow during primary angioplasty.

Tanzilli G, Greco C, Pasceri V, Pelliccia F, Arrivi A, Placanica A, Mangieri E.

Catheter Cardiovasc Interv. 2010 Nov 15;76(6):787-93. doi: 10.1002/ccd.22724.

PMID:
20737584
15.

Thrombus aspiration in patients with ST elevation myocardial infarction: meta-analysis of 16 randomized trials.

Tanboğa İH, Topçu S, Aksakal E, Kurt M, Kaya A, Oduncu V, Sevimli S.

Anatol J Cardiol. 2015 Mar;15(3):175-87. doi: 10.5152/akd.2015.6114.

16.

Oxygen therapy for acute myocardial infarction.

Cabello JB, Burls A, Emparanza JI, Bayliss SE, Quinn T.

Cochrane Database Syst Rev. 2016 Dec 19;12:CD007160. doi: 10.1002/14651858.CD007160.pub4. Review.

PMID:
27991651
18.

Fibrates for secondary prevention of cardiovascular disease and stroke.

Wang D, Liu B, Tao W, Hao Z, Liu M.

Cochrane Database Syst Rev. 2015 Oct 25;(10):CD009580. doi: 10.1002/14651858.CD009580.pub2. Review.

PMID:
26497361
19.

Interventions for prevention of herpes simplex labialis (cold sores on the lips).

Chi CC, Wang SH, Delamere FM, Wojnarowska F, Peters MC, Kanjirath PP.

Cochrane Database Syst Rev. 2015 Aug 7;(8):CD010095. doi: 10.1002/14651858.CD010095.pub2. Review.

PMID:
26252373
20.

SYNTAX score is a predictor of angiographic no-reflow in patients with ST-elevation myocardial infarction treated with a primary percutaneous coronary intervention.

Şahin DY, Gür M, Elbasan Z, Kuloğlu O, Şeker T, Kivrak A, Tanboğa İH, Gözübüyük G, Kirim S, Çayli M.

Coron Artery Dis. 2013 Mar;24(2):148-53. doi: 10.1097/MCA.0b013e32835c4719.

PMID:
23363986

Supplemental Content

Support Center